Drugs with this side effect
- 2-hydroxysuccinaldehyde: 8%
- 4-PBA: common
- 5-ASA: very rare, postmarketing
- 5-FU
- 5-aza-2'-deoxycytidine: 6.06% - 27.7%
- 5-azacytidine: very common, 0.98% - 48.2%
- 5-fluorocytosine
- 6-mercaptopurine
- 68Ga
- A77 1726: 1%
- APAs
- Anidulafungin: 0.667% - 1.33%
- BCNU
- Benicar-HCT
- CAS 76095-16-4
- CGP 19835A: common
- Carfilzomib: 0.19% - 13.5%
- D-penicillamine: 2%
- EACA
- FAMP
- FK463
- FTY720: common, 3%
- FdUrd
- Ge-132: 7%
- Glat copolymer: infrequent
- Goserelin
- ICI 182,780: postmarketing
- K779: postmarketing, 0% - 26%
- L-Dmp: infrequent
- Lisinopril: very rare, postmarketing
- MDV3100
- Madopar
- Meropenem anhydrous: postmarketing
- Mersyndol
- Metrodin
- NTBC: common
- Optison
- Romidepsin: 0% - 55.3%
- Stalevo 50
- Supremon
- T-A2-3
- Timentin
- UDCA
- VACV: very rare, postmarketing, 0.6% - 8%
- Zyprexa Relprevv
- abacavir
- acamprosate: rare
- acetaminophen
- acetazolamide
- actinomycin D
- acyclovir: very rare
- albendazole: 0.7%
- allopurinol
- amantadine: very rare
- aminoglutethimide
- amisulpride: postmarketing
- amitriptyline
- amlodipine
- amlodipine besylate
- amoxapine
- amoxicillin: very rare, postmarketing
- amphotericin B: 15.1% - 17.2%
- ampicillin
- amsacrine
- anastrozole
- anthracycline
- aripiprazole: uncommon
- arsenic trioxide
- asenapine
- aspirin
- atovaquone: 4%
- auranofin: postmarketing, 1.3% - 2.2%
- axitinib
- azathioprine: 28%
- azithromycin: postmarketing
- benazepril
- benazeprilat
- bendamustine: 18%
- benzathine penicillin
- bexarotene: very common, 0% - 47.2%
- bleomycin hydrochloride
- boceprevir: common
- bortezomib
- bosentan: postmarketing
- bosutinib
- bromcresol green
- bumetanide
- bupropion: postmarketing
- buspirone: rare
- busulfan
- cabazitaxel: 42% - 95.6%
- candesartan: postmarketing
- candesartan cilexetil: postmarketing
- capecitabine: 0.2% - 88%
- capreomycin
- carbamazepine: very rare, postmarketing, rare, very common
- carbenicillin
- carbidopa
- carbimazole
- carboplatin: 85%
- carisoprodol: postmarketing
- carvedilol
- cefaclor: postmarketing
- cefazolin: postmarketing
- cefdinir: postmarketing
- cefditoren
- cefepime: postmarketing
- cefixime: postmarketing
- cefotaxime
- cefotetan
- cefoxitin
- cefpodoxime
- ceftazidime: uncommon
- ceftizoxime
- ceftriaxone: postmarketing, 2% - 2.1%
- cefuroxime: postmarketing
- cefuroxime axetil
- celecoxib
- cephalexin
- cerivastatin
- cevimeline
- chlorambucil
- chloramphenicol
- chlorpromazine
- chlorpropamide
- chlorthalidone: rare
- choline theophyllinate
- cidofovir: postmarketing
- cilazapril
- cilostazol: postmarketing
- cimetidine: rare
- ciprofloxacin: postmarketing, rare, 0.4%
- cisplatin
- citalopram: postmarketing, rare, infrequent, uncommon
- clarithromycin: postmarketing
- clindamycin
- clindamycin phosphate
- clobazam: postmarketing
- clofarabine: 87.7%
- clomipramine: very rare
- clonazepam
- clopidogrel: postmarketing, uncommon
- clozapine: 3%
- colchicine: postmarketing
- copolymer 1
- crizotinib: 9%
- cyclobenzaprine: postmarketing
- cyclophosphamide
- cyproheptadine
- cyproterone
- cyproterone acetate
- cysteamine: uncommon
- cytarabine
- dabrafenib: 0% - 62%
- dacarbazine
- dalbavancin
- danazol
- dantrolene
- darunavir
- deferoxamine
- delamanid
- delavirdine
- deprenyl: rare
- dexrazoxane
- diatrizoate
- diazepam
- diazoxide
- dichlorphenamide
- diclofenac: very rare
- dicloxacillin
- didanosine: postmarketing
- diethylpropion
- diltiazem: postmarketing
- docetaxel: 2% - 3%
- doripenem: postmarketing
- doxapram
- doxazosin: postmarketing
- doxepin
- doxorubicin: uncommon, common, very common, 1.5% - 98.1%
- doxycycline
- duloxetine: infrequent
- eletriptan: rare
- entacapone
- entecavir: postmarketing
- eribulin: 22.1%
- eslicarbazepine acetate
- esomeprazole magnesium
- estazolam: rare
- estramustine: 2% - 4%
- estramustine phosphate
- ethambutol
- ethosuximide
- etidronate: postmarketing
- etodolac
- etoposide: 91%
- etoposide phosphate
- everolimus: common, 0% - 37%
- exemestane
- famciclovir: 1.3%
- famotidine
- febuxostat
- felbamate: infrequent, 6.5%
- fenofibrate
- fentanyl
- flavoxate
- flecainide
- flucloxacillin
- fluconazole: postmarketing
- fluoxetine: rare
- fluphenazine
- fluphenazine decanoate
- flurazepam
- flurbiprofen
- flutamide
- fluticasone: postmarketing
- fluvastatin: postmarketing
- fluvoxamine: rare
- foscarnet
- fosinopril
- fosinoprilat
- fosphenytoin: infrequent
- fotemustine
- furosemide
- fusidic acid
- gabapentin: 0.5% - 1.1%
- gadobenate dimeglumine
- ganciclovir: 0.8% - 3.2%
- gemcitabine: very common, 0% - 93%
- gemfibrozil
- gemifloxacin
- gentamicin
- glibenclamide
- gliclazide
- glimepiride: postmarketing
- glipizide: postmarketing
- gold sodium thiomalate: 2%
- granisetron: 9%
- griseofulvin
- guanidinium
- haloperidol: very rare, postmarketing
- hexamethylmelamine
- histamine
- hydralazine: uncommon
- hydrochlorothiazide
- hydroflumethiazide
- hydromorphone
- hydroxychloroquine
- hydroxyurea
- ibuprofen
- icodextrin: postmarketing
- idarubicin
- ifosfamide
- iloperidone
- imatinib: 0.3% - 19.6%
- imipramine: very rare
- indapamide
- indomethacin
- iodide
- irbesartan
- irbesartan-hydrochlorothiazide
- irinotecan: 0% - 98.6%
- isosorbide-5-mononitrate
- isradipine
- itraconazole: postmarketing
- ivermectin
- ixabepilone: 1% - 41%
- ketoconazole
- ketorolac: postmarketing
- ketorolac tromethamine: postmarketing
- lamivudine
- lamotrigine: infrequent
- lanreotide
- lansoprazole: postmarketing
- lapatinib: 1% - 33%
- leflunomide: postmarketing, rare, common, 3%
- lenalidomide: very common, 3.97% - 14.9%
- letrozole: uncommon
- leucovorin: 14% - 93%
- leuprorelin acetate: 1% - 18.3%
- levetiracetam: postmarketing
- levodopa/carbidopa
- lincomycin
- linezolid: postmarketing
- lithium carbonate
- lomefloxacin: 0.1%
- lomustine
- losartan
- lovastatin: postmarketing
- loxapine
- lurasidone: rare
- maprotiline
- maraviroc
- meclofenamate
- mefenamic acid
- mefloquine: postmarketing
- megestrol
- melatonin
- meloxicam
- melphalan: very common
- memantine: postmarketing, infrequent
- mephenytoin
- meprobamate
- meropenem: postmarketing
- mesna
- metaxalone
- methazolamide
- methimazole
- methocarbamol
- methotrexate
- methsuximide
- methyclothiazide
- methyldopa
- methylphenidate: very rare, postmarketing
- metoclopramide: postmarketing
- metolazone
- metoprolol
- metronidazole
- mexiletine
- mianserin
- milnacipran: postmarketing
- minocycline
- minoxidil
- mirtazapine: postmarketing, rare
- mitomycin C
- mitoxantrone: 9% - 9-100%
- molindone
- morphine: 2%
- moxifloxacin
- mycophenolate mofetil: 19% - 45.8%
- mycophenolic acid: 1% - 45.8%
- nabilone: postmarketing
- nabumetone: postmarketing, 0.4%
- naftifine: postmarketing
- nalidixic acid
- naproxen: postmarketing
- nedocromil sodium
- nefazodone: infrequent
- nelarabine: 7% - 38%
- nelfinavir: postmarketing, 0% - 5.13%
- niacin
- nifedipine: postmarketing
- nilotinib
- nilutamide: 3%
- nisoldipine
- nitrazepam
- nitrofurantoin
- nitrogen mustard
- nitrous oxide
- norfloxacin: postmarketing
- nortriptyline
- ofatumumab: 1% - 28%
- ofloxacin: postmarketing
- olanzapine: postmarketing, rare, infrequent, common, 1%
- olmesartan
- olsalazine
- omeprazole: postmarketing, rare
- oxaliplatin: 0% - 35%
- oxaprozin
- oxazepam
- oxcarbazepine
- oxycodone
- paclitaxel: very common, 72% - 90%
- paliperidone
- pamidronate: very rare, 0% - 4%
- pantoprazole: very rare, postmarketing
- paricalcitol
- paroxetine: infrequent, uncommon
- pazopanib: 0% - 44%
- pemetrexed: 0% - 55%
- penciclovir: 1.3%
- penicillin
- penicillin V
- pentamidine
- pentosan polysulfate
- pentostatin: 15% - 60%
- pentoxifylline
- pergolide: infrequent
- perindopril: very rare
- perindopril erbumine: postmarketing
- perindoprilat: postmarketing
- perphenazine
- phenelzine
- phenylbutyric acid
- phenytoin: infrequent
- pilocarpine
- pimozide: postmarketing
- piperacillin
- piroxicam
- pixantrone
- polythiazide
- pomalidomide: 5.61% - 17.9%
- ponatinib: 12% - 63%
- posaconazole
- pralatrexate
- pramipexole
- prasugrel: 2.8% - 3.5%
- pravastatin: postmarketing
- pregabalin: infrequent
- primaquine
- probenecid
- procaine penicillin
- procarbazine
- prochlorperazine
- promethazine
- propafenone: postmarketing
- propylthiouracil
- protriptyline
- pyrimethamine
- quetiapine: postmarketing, frequent, 2%
- quinidine
- rabeprazole: postmarketing
- radium: 3% - 35%
- raltitrexed: 18-23%
- ramipril: postmarketing
- ramiprilat: postmarketing
- ranitidine
- ranolazine
- rapamycin: postmarketing, 8% - 20%
- rasagiline: common
- reboxetine
- regorafenib
- repaglinide
- retigabine
- ribavirin: common, 4% - 10%
- rifabutin: 17%
- rifampicin
- rifapentine
- riluzole: infrequent, uncommon
- risperidone: postmarketing, rare, infrequent
- ritonavir
- rofecoxib
- ropinirole: infrequent, frequent
- rosiglitazone
- rufinamide: infrequent
- samarium: 59.3%
- saquinavir
- sertraline: postmarketing, rare
- sibutramine
- sildenafil
- silver nanoparticles
- silver sulfadiazine
- simvastatin: postmarketing
- sitaxsentan
- sorafenib: postmarketing, very common
- sotalol: postmarketing
- spironolactone
- stavudine: postmarketing
- streptomycin
- streptozotocin
- strontium
- sulfadiazine
- sulfamethoxazole
- sulfasalazine: 3%
- sulindac
- sunitinib
- tacrolimus: common, 10% - 48%
- tamoxifen
- telavancin: uncommon
- telithromycin
- temozolomide: uncommon, common, 0% - 4%
- temsirolimus
- teniposide: 89%
- tenoxicam
- testosterone enanthate
- testosterone undecanoate
- tetrabenazine
- thalidomide: 0% - 25.8%
- thiabendazole
- thiazide
- thioridazine: postmarketing
- thiotepa
- thiothixene
- tiagabine: infrequent
- tigecycline
- tinidazole
- tiopronin
- tizanidine: infrequent
- tobramycin
- tolazamide
- tolbutamide
- topiramate: postmarketing, 0% - 2.7%
- topotecan: very common, 91% - 97%
- torasemide: postmarketing
- toremifene
- trabectedin
- trametinib: 0% - 62%
- trandolapril: postmarketing
- tranylcypromine
- trifluoperazine
- trimethadione
- trimethoprim: very rare
- trimethoprim-sulfamethoxazole: very rare
- trovafloxacin
- v 1784: postmarketing, common, 0% - 19%
- valdecoxib
- valganciclovir: 4% - 20.1%
- valproate: postmarketing
- venlafaxine: infrequent
- vinblastine
- vincristine
- vinflunine
- vinorelbine: 0% - 99%
- voriconazole: common, 0% - 0.51%
- vorinostat
- zalcitabine
- zidovudine: postmarketing, common
- zidovudine/lamivudine
- ziprasidone: infrequent
- zoledronic acid: uncommon
- zolmitriptan: rare
- zolpidem: rare
- zonisamide: infrequent
- zuclopenthixol
|
Drugs with this indication
|
